Adagene Inc. (ADAG)
NASDAQ·Healthcare·Biotechnology
$3.24
+0.94%
Mkt Cap $115.00M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$8.67
Range $7.00 – $10.00
Implied Upside
+167.6%
Consensus $8.67 vs current $3.24
NASDAQ·Healthcare·Biotechnology
$3.24
+0.94%
Mkt Cap $115.00M
No recent rating data.
Price Target (5 analysts)
$8.67
Range $7.00 – $10.00
+167.6%
Consensus $8.67 vs current $3.24